A clinical study to determine the efficacy of Amritadya Guggulu and Haritaki Churna in the management of Medoroga w.s.r. to Dyslipidemia

Abstract

Dyslipidemia, a significant risk factor for atherosclerotic cardiovascular disease (ASCVD), necessitates effective management strategies. This study investigated the efficacy of an Ayurvedic formulation, Amritadya Guggulu combined with Haritaki Churna, in managing dyslipidemia compared to conventional treatment with Atorvastatin. Thirty patients with dyslipidemia were randomly assigned to two groups and received either the Ayurvedic formulation or Atorvastatin for 8 weeks. The results demonstrated that the Ayurvedic group showed statistically significant improvements in subjective symptoms and objective parameters, including serum cholesterol and triglyceride levels. Notably, no adverse effects were reported in this group. In contrast, the conventional treatment group exhibited improvements, but to a lesser degree. These findings suggest that Amritadya Guggulu and Haritaki Churna may serve as effective and safe alternatives for dyslipidemia management. Further investigation with larger sample sizes is warranted to provide conclusive evidence. This study contributes to the growing body of research on Ayurvedic interventions for non-communicable diseases, highlighting their potential in addressing public health concerns in developing countries.